AllDocs -> cancers

Neuroblastoma Incidence in Illinois: 1986-1994 Neuroblastomas are childhood tumors of the autonomic nervous system. The annual incidence rate among children under 15 years of age in the United States is nine to 11 cases per million. In Illinois, according to data reported to the Illinois State Cancer Registry for 1986 through 1994, the annual incidence rate was 10.3 per million. Table 1 lists numbers of neuroblastoma incidence among children less than 15 years of age by county in Illinois from 1986 though 1994. As one would expect, counties with a large population, such as Cook and Du Page, tend to have more cases. In order to detect unusually high incidence of neuroblastoma , numbers in Table 1 need to be related to their population denominators, compared with the expected number of cases based on the overall neuroblastoma incidence in Illinois, and expressed in terms of probabilities. This was done by calculating ...

neuroblastoma 1146 Neuroblastoma THE FACTS: What is it? Neuroblastoma is a form of cancer, found primarily in children, that attacks the developing nerve cells. In Neuroblastoma , cancerous tumors form from cells called neural crest cells . These cells are similar to those found in the developing nervous systems of an embryo or a fetus. The human body has two glands known as adrenal glands , one above each kidney. These glands are triangular in shape and are responsible for secreting hormones that control the body’s involuntary responses such as blood pressure and heart rate. Neuroblastoma can start in the bundle of nerves in the adrenals, as well as in the nerve groups in other parts of the body responsible for the body’s involuntary responses. &n...

neuroblastoma SUPPLEMENTARY MATERIALS for Stupack et al., Nature Manuscript # 2004-11-26405D Supplementary Figure S1 Supplementary Figure S1 Caspase expression and survival among human neuroblastoma within the tissue stroma of the chick chorioallantoic membrane. a, Supplementary wide field images of Celltracker red-labeled neuroblastoma cells (red fluorescence) infiltrating the CAM stroma adjacent to the primary tumor, as imaged via confocal microscopy. TUNEL-staining was used to reveal apoptotic cells (green fluorescence), and colocalization analysis was performed (Merge, yellow signal). The tumor margin ...

Neuroblastoma – the basics Disclaimer: This fact sheet is for education purposes only. Please consult with your doctor or other health professional to make sure this information is right for your child. This information sheet will tell you in simple terms: What is a neuroblastoma ? Why did the neuroblastoma happen? What problems does neuroblastoma cause? How did we find the neuroblastoma ? How do we treat neuroblastoma ? What is a neuroblastoma ? A neuroblastoma is a type of cancer - a lump of cells (tumour) which should not be there. Neuroblastoma is a cancer that only children get. It starts from primitive (very simple) nerve cells found in areas where nerves join together. The most common areas where these are found are in the abdomen (especially the adrenal gland), chest and neck. Why did the neuroblastoma happen? In most cases, we do not know why children get ...

Neuroblastoma Protocol applies to the examination of specimens from patients with neuroblastoma and related neuroblastic tumors. Protocol date: July 2005 No AJCC/UICC staging system Procedures • Cytology (No Accompanying Checklist) • Incisional Biopsy (Needle or Wedge) (No Accompanying Checklist) • Resection Authors Stephen J. Qualman, MD Department of Laboratory Medicine, Children’s Hospital, Columbus, Ohio Jay Bowen, MS Department of Laboratory Medicine, Children’s Hospital, Columbus, Ohio Patrick L. Fitzgibbons, MD Department of Pathology, St. Jude Medical Center, Fullerton, California Susan L. Cohn, MD Department of Pediatrics, Northwestern University, Chicago, Illinois Hiroyuki Shimada, MD, PhD Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, California For the Members of the ...

Thiele CJ. Neuroblastoma : In (Ed.) Masters, J. Human Cell Culture. Lancaster, UK: Kluwer Academic Publishers. 1998, Vol 1, p 21-53 Neuroblastoma Cell Lines Carol J. Thiele Cell & Molecular Biology Section, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bld. 10 Rm 13N240, 10 Center Dr. MSC1928, Bethesda, MD. 20892-1928; fax 301-402-0575; thielec@pbmac.nci.nih.gov Page 2 2 Historical Introduction Neuroblastoma accounts for approximately 9% of all childhood cancers, occurring once out of 8,000 live births. This results in an annual incidence of approximately 1 in 10 5 children less than 15 years of age world-wide (1) . The median age at diagnosis is approximately 22 months with over one-third diagnosed at less than 1 year of age and over 88% diagnosed by the age of 5. Some studies ...

Mechanisms of bone invasion and metastasis in human neuroblastoma Yasuyoshi Sohara a , Hiroyuki Shimada b , Yves A. DeClerck a,c, * a Division of Hematology–Oncology, Department of Pediatrics, Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA b Department of Pathology, Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA c Department of Biochemistry and Molecular Biology, Childrens Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA Received 2 December 2004; accepted 12 January 2005 Abstract Bone is the second most common site of metastasis in neuroblastoma . Over the last several years, our understanding of the mechanism of bone metastasis in ...

Educational Session Neuroblastoma ASCO 2005 ASCO High-Risk Neuroblastoma : Beyond Intensification to Novel Therapy Approaches to Improve Outcome Chair Katherine K. Matthay, MD Professor of Pediatrics Chief, Pediatric Hematology-Oncology University of California San Francisco School of Medicine San Francisco, CA 94143-0106 Speakers C. Patrick Reynolds, MD, PhD Professor of Pediatrics Director, Developmental Therapeutics Program USC-CHLA Institute for Pediatric Clinical Research Children’s Hospital Los Angeles University of Southern California Los Angeles, Ca 90027 Rogier Versteeg, MD Professor and Chair, Human Genetics Academic Medical Center University of Amsterdam P.O. Box 22700 1100 DE Amsterdam The Netherlands Page 2 Educational Session ...

Olfactory neuroblastomas are relatively uncommon tu- mors that originate from the olfactory epithelium in the upper nasal cavity in the region of the cribriform plate. Although some controversy persists, their primary modal- ity of therapy is resection, usually performed by an an- terior craniofacial approach and with the provision of ad- juvant radiation therapy. 29 In addition, recent experience suggests that there may be a therapeutic role for adjuvant chemotherapy. 4 A variety of other neoplastic lesions occur in the same anatomical region as ONs. Tumors such as NEC, melanoma, sinonasal lymphoma, SNUC, and pitu- itary adenoma can all present with similar clinical, histo- logical, and radiological features as ON. The prognosis and therapeutic modalities for these different tumors are variable, and physicians treating neoplasms arising from the paranasal sinus region ...

Efficacy of Complete Resection for High-Risk Neuroblastoma : A Children’s Cancer Group Study By E. Stanton Adkins, Robert Sawin, Robert B. Gerbing, Wendy B. London, Katherine K. Matthay, and Gerald M. Haase Columbia, South Carolina; Seattle, Washington; Arcadia, California; Gainesville, Florida; San Francisco, California; and Denver, Colorado Background/Purpose: Previous reports indicate that com- plete resection of high-risk neuroblastoma improves out- come but may entail high surgical complication rates. The authors evaluated the effect of complete primary site resec- tion on event-free survival (EFS), overall survival (OS), and complication rates in patients entered on a high-risk neuro- blastoma treatment protocol. Methods: A total of 539 eligible patients with high-risk neu- roblastoma were entered on protocol CCG-3891. Patients were assigned randomly to continuation chemotherapy ...